Vaccine 4 1 1 for 6-30-2020 - tracking the race to find a cure for the Coronavirus - Covid 19

<p>On this episode of Vaccine 411… a vaccine that would not only prevent COVID-19, but could also treat active infections.&nbsp;Sign us up!</p><p>First, the latest vaccine news from around the world:&nbsp;</p><p>Brazil:&nbsp;Federal regulator approval is expected this week for Phase III trials of Sinovac’s Coronavac vaccine to begin.&nbsp;9,000 volunteers have already been registered reports U.S. News and World Report.&nbsp;Brazil also signed an agreement to produce Oxford University/AstraZeneca’s vaccine candidate.&nbsp;</p><p>China:&nbsp;&nbsp;CanSino Biologics vaccine was approved for limited use within the Chinese military.&nbsp;The company published Phase I data in May, Phase II data has yet to be published.&nbsp;Citing competitive reasons, the company would not say if the vaccine would be mandatory for all service members.&nbsp;</p><p>United States:&nbsp;Gilead Sciences, the maker of Remdesivir, will typically charge hospitals $3,120/patient for those with private insurance.&nbsp;Other developed countries will pay about 25% less per patient.&nbsp;The Trump Administration has secured half a million doses for U.S. hospitals.&nbsp;&nbsp;</p> &#10;&nbsp;<br /><hr><p style='color: grey; font - size: 0.75em; '>See <a style='color: grey; ' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for privacy and opt-out information.</p>